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Cellular plasticity is a major focus of investigation in developmental biology. The recent discovery that
induced neuronal (iN) cells can be generated from mouse and human fibroblasts by expression of defined
transcription factors suggested that cell fate plasticity is much wider than previously anticipated. In this
review, we summarize the most recent developments in this nascent field and suggest criteria to help define
and categorize iN cells that take into account the complexity of neuronal identity.Introduction
Somatic cell nuclear transfer and in vitro induction of pluripo-
tency in somatic cells by defined factors provided unambiguous
evidence that the epigenetic state of terminally differentiated
somatic cells is not static and can be reversed to amore primitive
one (Gurdon, 2006; Jaenisch and Young, 2008; Yamanaka and
Blau, 2010). Inspired by these results, stem cell biologists have
recently identified approaches to directly convert fibroblasts
into induced neuronal (iN) cells, indicating that direct lineage
conversions are possible between very distantly related cell
types (reviewed in Vierbuchen and Wernig, 2011). Importantly,
iN cells can also be derived from defined endodermal cells.
The reprogramming process both induces neuronal properties
and extinguishes prior donor cell identity, and therefore repre-
sents a complete and functional lineage switch as opposed to
generation of a chimeric phenotype. Since the discovery in the
late 1980s that MyoD, a key regulatory transcription factor in
the skeletal muscle lineage, can induce many features of muscle
cells in fibroblasts, several other examples of remarkable cell-
fate changes have been observed in response to forced expres-
sion of transcriptional regulators, but until recently it was
assumed that this phenomenon is limited to closely related cell
lineages (for discussion and historical background, see Graf,
2011, in this issue of Cell Stem Cell). After the initial description
of iN cells, additional studies showed that fibroblasts can be
directly converted to a diverse range of cell types, such as cardi-
omyocytes (Ieda et al., 2010), blood cell progenitors (Szabo
et al., 2010), and hepatocytes (Huang et al., 2011; Sekiya and
Suzuki, 2011). In this review, we discuss the recent advances
in direct lineage reprogramming toward the neuronal lineage
and propose criteria that can be used to identify successfully
reprogrammed iN cells.
Direct Conversion of Mouse Fibroblasts to Neurons
As transcription factors play key determining roles in cell fate
specification, we hypothesized that forced expression of
a combination of such factors may be sufficient to directlyconvert mouse fibroblasts into neuronal cells (Vierbuchen
et al., 2010). Following lentiviral expression of 19 candidate
genes, we detected cells with neuronal morphologies and
expression of neuronal markers, which suggests that such
a conversion may indeed be possible. A systematic evaluation
of different combinations revealed that the five transcription
factors Ascl1, Brn2, Olig2, Zic1, and Myt1l are the most critical
genes for this process. Out of those five factors, the pool of
Brn2, Ascl1, and Myt1l (BAM) was shown to be sufficient to
induce neuronal cells that exhibited both molecular and all prin-
cipal functional properties of neurons (Figure 1). Surprisingly, the
conversion efficiency of embryonic fibroblasts was estimated to
be close to 20% within 2 weeks, indicating that the conversion
toward neuronal fates is substantially faster and more efficient
than iPSC formation. Also in contrast to induction of pluripo-
tency, iN cell reprogramming does not require cell proliferation,
which is arguably a more favorable condition for epigenetic
changes and a key mediator of iPSC reprogramming (Hong
et al., 2009; Kawamura et al., 2009; Li et al., 2009; Mario´n
et al., 2009; Utikal et al., 2009).
This first iN cell study raised many new questions that the field
has now begun to address. Among other things, it was unclear
what the exact cell of origin for iN cells was and whether endo-
dermal cells could be coaxed toward an iN cell fate. From
a developmental perspective, it remained unresolved whether
the reprogramming involved an intermediate neural progenitor
cell state, how similar iN cells are compared to bona fide
neurons, whether iN cells possessed a regional identity, and if
modifying the combination of transcription factors would bestow
a specific neural subtype identity. Chromatin biologists would be
interested to know how completely the epigenetic landscape is
remodeled toward a neuronal pattern and whether the reprog-
ramming factors initiate the neurogenic programwhile suppress-
ing the original cell fates or whether iN cells retain molecular
‘‘memories’’ of their cell of origin. In relation to potential transla-
tional application, questions also remained about whether iN
cells can functionally integrate into the brain, and last but notCell Stem Cell 9, December 2, 2011 ª2011 Elsevier Inc. 517
Figure 1. Summary of Induced Neural Lineage Cells to Date
Several proof-of-principle studies have established the possibility of generating different subtypes of induced neuronal cells as well as neural precursor cells from
mouse and/or human fibroblasts. Diagrammed here are examples from mouse and human fibroblasts to excitatory (although iN cells expressing inhibitory-
neuron-specific markers can be occasionally detected by multiple groups, or IPSCs can even be recorded from iN cells cocultured with mouse glial cells [Yoo
et al., 2011], the main majority of iN cells produced are excitatory cells), dopaminergic, andmotor iN cells. Marro et al. (2011) also described the direct conversion
frommouse hepatocytes to excitatory iN cells. The parentheses indicate alternative reprogramming factors from different studies that result in the same neuronal
subtype.
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iN cells. In the past few months a number of reports have
provided the first answers to some of these questions.
A Direct Endoderm-to-Ectoderm Switch
In order to address some of the outstanding questions, we
looked at converting definitive endodermal cells into iN cells
(Marro et al., 2011). Intriguingly, we found that the exact same
three reprogramming factors were sufficient to induce iN cells
from primary liver cultures as from fibroblasts. Taking advantage
of a well-characterized Albumin-Cre allele, we unequivocally
confirmed that Albumin-expressing hepatocytes were the origin
of iN cells, thereby demonstrating that transcription-factor-
mediated lineage reprogramming is possible across major
lineage boundaries. We were also able to assess the transcrip-
tional network dynamics during reprogramming and to compare
the expression profile of fibroblast- and hepatocyte-derived iN
cells. These results indicated that the timing of the two reprog-
ramming processes is different and that hepatocytes appear to
be more resistant to the lineage switch. Moreover, we also
explored how thoroughly iN cells are reprogrammed. We found
that the donor-cell-type-specific expression signatures were
robustly silenced in both fibroblast- and hepatocyte-derived iN
cells. Thus it seems that the exact same three transcription
factors not only can induce a neuronal program, but can also
downregulate two unrelated donor transcriptional programs.
Detailed gene expression analysis at a population- and single-
cell-level indicated that iN cells possess a limited degree of
epigenetic memory of their donor cells, but these transcriptional
remnants decreased over time. It will be interesting to investigate
the molecular mechanism underlying the transcriptional518 Cell Stem Cell 9, December 2, 2011 ª2011 Elsevier Inc.silencing that occurs, and to see whether it is similar to mecha-
nisms that are used during cell fate specification in the embryo.
Given the substantial differences between the fibroblast and liver
transcriptional programs, it seems unlikely that the transcrip-
tional silencing is directly mediated by the neuronal transcription
factors themselves. Nevertheless, it is a formal possibility that
the BAM factors target and inhibit a large number of key
lineage-determining factors representing many nonneuronal
cell fates. Alternatively, the mutual lineage switch could be
caused by a more general mechanism. Perhaps when cells are
becoming specified to one particular lineage a process becomes
activated that leads to transcriptional silencing of many other
lineage programs. For example, lineage-determining factors
may have to compete for a finite amount of certain ubiquitously
expressed and required cofactors, which would lead to suppres-
sion of undesired lineages once differentiating cells have
committed to one lineage. E-proteins could potentially be one
such critical cofactor as they are known to heterodimerize with
many different lineage-specific bHLH transcription factors (Mas-
sari and Murre, 2000).
iN Cells from Human Fibroblasts
Another important question that remained open after our initial
publication was whether iN cells could also be generated from
human fibroblasts. This issue is important because potential clin-
ical applications could only be realized with human cells. As the
exact same four transcription factors can reprogram bothmouse
and human fibroblasts into iPSCs, one might have expected that
converting human fibroblasts to iN cells could be achieved in the
same way as that used for mouse fibroblasts. However, when
the BAM factors were introduced into human fetal fibroblasts,
Cell Stem Cell
Reviewthe resulting cells remained immature and failed to generate
action potentials when depolarized (Pang et al., 2011). This
finding was later confirmed by another group that reported little
reprogramming by the BAM factors in human cells, and in this
case, attributed to pronounced cell death (Qiang et al., 2011).
We therefore screened 20 additional factors in combination
with BAM and found that by introducing the bHLH factor Neu-
roD1, the generation of functional neuronal cells from human
fibroblasts can be achieved. These human iN cells expressed
a variety of neuronal markers including Tuj1, MAP2, NeuN, Neu-
rofilament, and Synapsin and exhibited functional neuronal
properties as judged by the measurement of action potentials.
Moreover, when cultured with primary cortical neurons, both
spontaneous and evoked postsynaptic currents could be de-
tected in these cells, demonstrating their synaptic maturation.
However, the first functional synapses were found only after 5–
6 weeks, suggesting that the full maturation of human iN cells
is a slow process. The same four factors could also convert post-
natal foreskin fibroblasts into synaptically competent iN cells
with comparable timing and efficiency. Like mouse iN cells,
most of the human iN cells expressed mRNAs characteristic of
glutamatergic neurons, such as vGLUT1 and vGLUT2. After
downregulation of the exogenous transcription factors, the iN
cells retained their stability, which indicated that an intrinsic
program was established to maintain the newly adopted
neuronal identity. The overall efficiency of generating human iN
cells with four factors (2%–4%) was about 10-fold lower than
that of mouse with just three factors (compare to Vierbuchen
et al., 2010). The observed species differences in the iN cell re-
programming may appear unexpected in light of the robustness
of generating human iPSCs. However, upon closer inspection,
the two different human reprogramming paradigms do share
many similarities. The drop in human iPSC reprogramming effi-
ciency as compared to mouse is of a similar magnitude, espe-
cially when taking into account that only a small fraction of plated
fibroblasts and only a small subset of these cells’ progenies are
forming iPSCs. Similarly, it takes much longer for iPSC-like colo-
nies to appear with human fibroblasts as compared to those of
mouse. Thus, human cells in general appear to be less plastic
and have a higher epigenetic ‘‘hurdle’’ for reprogramming to
both iN cells and iPSCs. Finally, human ESC-derived neurons
require amounts of time to develop synaptic competence that
are similar to those of human iN cells (Johnson et al., 2007; Wu
et al., 2007). Thus, a long maturation time may be an inherent
property of human cells, which is perhaps not surprising given
that human brain development is orders of magnitude slower
than that of rodents.
In attempts to convert adult human fibroblasts to neurons,
another group turned to using the five factors that we initially
found in mouse to be the most critical of the 19 tested candidate
factors. The resulting cells possessed a series of neuronal prop-
erties including certain functional properties such as the ability to
generate action potentials when depolarized (Qiang et al., 2011).
The acquisition of more mature functional properties such as
synaptic transmission was less clear. This observation is similar
to ours when adult fibroblasts were infected with BAM and
NeuroD1 (Pang et al., 2011). Nevertheless, iN cells were gener-
ated from Familial Alzheimer’s Disease (FAD) patients with muta-
tions in PSEN genes and were found to exhibit disease-specifictraits, providing important proof-of-concept that iN cells can be
used to model human disease. Specifically, the FAD-iN cells
showed the presence of amyloid precursor protein (APP) puncta
in endosomes, which was not readily detected in the originating
FAD fibroblasts. This phenotype could be rescued by overex-
pression of wild-type PSEN1. Of note, one of the reprogramming
factors used in this study is Olig2, another member of bHLH
family. Olig2 is not specific to neurons and can promote both
neuronal and oligodendroglial fates depending on the develop-
mental context (Mizuguchi et al., 2001; Novitch et al., 2001;
Zhou et al., 2001; Lu et al., 2002; Park et al., 2002; Takebayashi
et al., 2002). However, in contrast to Ascl1 and NeuroD1, Olig2 is
thought to act as a repressor, and to associate with Ngn2 and
E47 to antagonize their neurogenic effect (Lee et al., 2005).
Future work will need to elucidate the function of these transcrip-
tion factors during reprogramming. As a number of different tran-
scription factor combinations can induce neuronal cells, there
may be several parallel pathways to the neuronal lineage. Alter-
natively, the different transcription factors may eventually acti-
vate the same core program to induce neuronal identity.
The fact that the vast majority of reprogramming factors
known to date are transcriptional regulators is not surprising
given their ability to efficiently activate gene expression, and it
also fits with the idea that this gene class contains ‘‘master regu-
lators’’ and ‘‘terminal selectors’’ for specific lineages (Weintraub
et al., 1989; Hobert, 2011). It is surprising, however, thatmiRNAs,
which are thought to function predominantly through downregu-
lation of gene activity, seem to be very powerful agents to
mediate reprogramming. Two independent groups have recently
derived human and mouse iPSCs by adding miRNAs in the
absence of any additional transcription factors (Anokye-Danso
et al., 2011; Miyoshi et al., 2011). Similarly, Yoo et al. (2011)
showed that by introducing miR-9/9* and miR-124, human fibro-
blasts can be reprogrammed into cells with neuron-likemorphol-
ogies expressing the panneuronal marker MAP2. While these
phenotypic changes are truly remarkable, the miRNAs alone
were not sufficient to induce functional iN cells. However, the
addition of the transcription factors NEUROD2, ASCL1, and
MYT1L greatly increased the conversion efficiencies and led to
the formation of iN cells from fetal and adult human fibroblasts
with all the major functional properties of neurons, including
synapse formation. Intriguingly, this report also underscored
the essential role of bHLH transcription factors for generation
of human iN cells. miR-9* and miR-124 are specifically ex-
pressed in postmitotic neurons and were shown to repress the
expression of SWI/SNF complex subunit Baf53a. When neural
progenitor cells exit the cell cycle and differentiate into neurons,
Baf53a is replaced by Baf53b and this switch is functionally rele-
vant (Yoo et al., 2009). Therefore, one possibility was that the
miRNAs facilitated reprogramming through promoting this BAF
complex subunit switch. However, prolonging the expression
of BAF53a did not abolish the conversion from fibroblasts to
neurons, and therefore downregulation of this miRNA target
does not seem to be critical in this context (Yoo et al., 2011).
As we showed iN cell induction by NeuroD1, Ascl1, Myt1l, and
Brn2, it appears that the miRNAs are able to replace the tran-
scription factor Brn2 (Pang et al., 2011). However, this idea
was not tested directly, however, and it is possible that the
miRNAs work through yet another mechanism. More recently,Cell Stem Cell 9, December 2, 2011 ª2011 Elsevier Inc. 519
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cell formation (Ambasudhan et al., 2011). In this report the
miRNAwas combinedwith BRN2 andMYT1L, further supporting
the idea the miRNAs have a complementary function to Brn2.
Surprisingly, no bHLH transcription factors were used in the
latter report, but the cells also appeared less completely reprog-
rammed based on the absence of convincing evidence for
synaptic competence. Future studies on the miRNA-transcrip-
tion factor interplay responsible for iN cell formation could also
be relevant to regular neural development. Thus, this extremely
nonphysiological method of reprogramming could perhaps
even become a discovery tool for understanding normal devel-
opment.
Induction of Specific Subtypes of Mouse and Human
iN Cells
For clinical and experimental use of iN cells, it would be desirable
to develop ways to generate neurons with neurotransmitter- and
region-specific phenotypes. Liver and fibroblast iN cells gener-
ated with the same reprogramming factors displayed properties
characteristic of excitatory neurons. While this property does not
in itself imply the acquisition of a particular region-specific
phenotype, it could mean that the glutamatergic fate is a default
fate as has been suggested for ESC differentiation systems (Tro-
pepe et al., 2001; Gaspard et al., 2008). Alternatively, the choice
of transcription factors could have specifically induced an excit-
atory subtype. Therefore, the question arises of whether inclu-
sion of subtype-specific transcription factors in the reprogram-
ming cocktail could direct cells into other desired subtypes.
This hypothesis was elegantly tested by Son et al., who gener-
ated iN cells with motor neuron identity directly from fibroblasts
(Son et al., 2011) (Figure 1). Starting out with a fairly large pool of
transcription factors critical for motor neuron specification, they
eventually found that four factors (Lhx3, Hb9, Isl1, and Ngn2) in
combination with the BAM factors generated Hb9-positive
neurons with an efficiency of up to 10% from MEFs. Gene
expression analyses indicated that these induced motor
neuronal (iMN) cells resemble the embryonic and ESC-derived
motor neurons in transcription profiles. Besides displaying elec-
trophysiological properties akin to those of motor neurons, these
iMN cells also formed functional synaptic connections with my-
otubes. When transplanted to the developing chick spinal cord,
most of the iMN cells were engrafted in the ventral horn of the
spine with axons projecting into the ventral roots. In addition,
the cells behaved similarly to ESC-derived motor neurons in
disease conditions. When cultured with glia carrying the G93A
mutation in the Superoxide dismutase (Sod1) gene, a mutation
found in familial forms of amyotrophic lateral sclerosis (ALS),
the survival of iMN cells decreased. Vice versa, iMN cells derived
from Sod1G93A MEFs also showed reduced survival when
cultured with wild-type glia. These first translational studies
suggest that iMN cells can be used as a tool to understand the
pathophysiology of ALS. As a first step in this direction, Son
et al. also infected human ESC-derived fibroblast-like cells
with the seven transcription factors in combination with Neu-
roD1. This approach yielded neuronal cells that could fire action
potentials and expressed Hb9 and vesicular ChAT. More work is
needed to investigate whether iMN cells can be generated from
primary human fibroblasts.520 Cell Stem Cell 9, December 2, 2011 ª2011 Elsevier Inc.Another clinically relevant neuronal subtype that has been
under intense investigation is the group of midbrain dopami-
nergic (DA) neurons, which are preferentially affected in Parkin-
son’s disease. Recently, two important proof-of-principle
studies described the generation of iN cells expressing tyrosine
hydroxylase (TH), the rate-limiting enzyme in catecholamine
biosynthesis (Caiazzo et al., 2011; Pfisterer et al., 2011). Pfisterer
et al. showed that Lmx1a and Foxa2, when used in conjunction
with the BAM pool, are capable of generating iN cells expressing
TH; Aromatic L-amino acid decarboxylase (AADC), another
crucial enzyme in catecholamine biosynthesis; and importantly,
Nurr1, a marker of midbrain identity. However, the cells did not
express other midbrain markers and were not able to release
dopamine into the media. Another report by Caiazzo et al.
demonstrated the generation of mouse iN cells with dopami-
nergic features by expression of the transcription factors
Ascl1, Nurr1, and Lmx1a. The fraction of TH-positive cells was
reported to be 18% based on a TH-EGFP transgenic reporter
line. The TH-positive cells coexpressed vesicular monoamine
transporter 2 (VMAT2), dopamine transporter (DAT), aldehyde
dehydrogenase 1a1 (ALDH1A1), and calbindin. In contrast to
the BAM/Foxa2/Lmx1a cells described by Pfisterer et al., the
Ascl1/Nurr1/Lmx1a iN cells were able to release dopamine as
determined by amperometry and HPLC analysis, indicating
that the cells possessed an important functional property of
dopamine neurons. Intriguingly, similar results could be obtained
using human fibroblasts and the same reprogramming factors.
However, the cells generated in this study did not express any
regional markers specific to midbrain and displayed immature
morphologies. Moreover, the authors did not investigate whether
the cells were competent to receive synaptic input. Therefore,
despite the use of midbrain dopamine neuron-specific transcrip-
tion factors for reprogramming, only generic dopamine neuron
and no midbrain-specific features were observed, suggesting
incomplete reprogramming. Similarly, genome-wide transcrip-
tional profiling showed substantial differences between the re-
programmed and brain-derived dopamine neurons.
As a cautionary note, the absence of midbrain character is
a critical limitation for clinical application, since only ‘‘authentic’’
human midbrain dopamine neurons are able to restore function
in animal models of Parkinson’s disease (Kriks et al., 2011; Roy
et al., 2006; Yang et al., 2008). Therefore, yet another group
very recently attempted to generate iN cells that are more remi-
niscent of midbrain dopamine neurons (Kim et al., 2011b). This
time transcription factor combinations were screened to induce
EGFP fluorescence in Pitx3:EGFP knockin fibroblasts, a locus
highly specific for midbrain dopamine neurons. Surprisingly,
EGFP-positive cells were readily detected with a combination
of two factors, Ascl1 and Pitx3. Complementation with another
four factors (Nurr1, Lmx1a, Foxa2, and En1) as well as the
patterning factors Shh and FGF8 further enhanced the induction
of Pitx3. The EGFP-positive cells also expressed the generic
dopamine neurons markers TH, DAT, AADC, and VMAT2 and
were able to release dopamine. However, when tested in vivo,
the cells only partially restored dopamine function, and when
a series of midbrain markers were analyzed, both the two-factor
and the six-factor iN cells failed to reach similar transcription
levels found in embryonic or adult midbrain dopamine neurons.
This finding leads to the somewhat sobering conclusion that
Figure 2. Direct versus Indirect Reprogramming
Long expression of the four Yamanaka factors leads to iPSC formation when
the fibroblasts are grown in ESCmedia (route 1); whereas the short expression
induces fibroblasts to a transient, unstable pluripotent state that can be quickly
differentiated into neural precursors or cardiomyocytes depending on the
media components (route 4). Direct reprogramming (e.g., iN cell reprogram-
ming) does not involve a pluripotent intermediate stage (route 3). Future
studies may demonstrate the possible direct conversion from fibroblasts to
neural precursor cells (route 2). Green arrows: reprogramming; gray arrows:
differentiation.
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reprogram fibroblasts to this specific neuronal subtype.
Directly generating terminally differentiated neurons could be
useful in disease modeling and transplantation studies.
However, a clear limitation of postmitotic iN cells is their inability
to expand once reprogrammed. Large numbers of cells will be
required for cell-replacement-based therapies in a clinical
setting, or for drug screening. Therefore, it would be desirable
to induce expandable neural precursor cells directly from fibro-
blasts. Recently, Ding and colleagues successfully converted
mouse fibroblasts to induced neural precursor cells (iNPCs)
(Kim et al., 2011a). In this study, the recipe for reprogramming
was not tailored to the target cell type, but was instead identical
to the iPSC reprogramming factors (Figure 2). However, unlike as
in iPSC formation, the factors were induced only for a short time,
and the cells were then exposed to media favoring the growth of
neural progenitor cells. After optimization of timing and culture
conditions, colonies that closely resembled neural rosette cells
appeared and expressed several relevant markers. Upon spon-
taneous differentiation, these iNPCs could give rise to multiple
neuronal subtypes and astrocytic cells, indicating that the iNPCs
were at least bipotential neural precursor cells, but cells with oli-
godendrocytic characteristics were not seen; notably, a very
similar approach was also used to generate cardiomyocytes
and blood progenitor cells from fibroblasts (Szabo et al., 2010;
Efe et al., 2011). In these studies, the authors concluded that
the observed transdifferentiation bypassed an intermediatepluripotent stage because no Oct4 transcripts were observed
in the cell population and the short reprogramming factor
expression was not compatible with iPSC generation. However,
as the same approach can generate multiple somatic as well as
pluripotent lineages, the simplest explanation is that short-term
expression of the pluripotency reprogramming factors indeed
induces a transient pluripotent state, but this state is unstable
and prone to differentiation, and cannot be stabilized by environ-
mental cues only (Figure 2). Future studies will address whether
a ‘‘direct’’ conversion between fibroblasts and neural progeni-
tors is possible using neural transcription factors (Figure 2).
Although this approach is intriguing, the efficiency of forming
rosette-like colonies appeared low and the cells could not be
expanded well. It remains to be seen what the similarities and
differences of these indirect and direct iNPCs will be and
whether such unstable pluripotent cells can also be generated
from human fibroblasts.
Defining Criteria for iN Cells
In recent months there has been a wave of reports published
describing various methods to generate iN cells of various sorts.
Given the infancy of the field, different criteria were applied to
define converted neuronal cells, complicating the direct compar-
ison of the different approaches. Consistent standards would be
helpful, and we would therefore like to suggest here a panel of
criteria that can be used to define iN cells with various degrees
of reprogramming. First, we propose the term ‘‘induced neuronal
cells (iN cells)’’ as opposed to ‘‘induced neurons,’’ to contrast re-
programmed cells with brain-derived cells. Second, we propose
that the term ‘‘iN cell’’ should only be endorsedwhen the extent of
reprogramming can be documented as being reasonably
complete. In a nutshell, we believe fully reprogrammed iN cells
should have a distinct neuronal morphology, express neuron-
specific gene products, and exhibit the two principal functional
properties of neurons: action potentials and synaptic transmis-
sion. This level of validation would be equivalent to that used for
in-vitro-generated neurons from neural or embryonic stem cells
in previous work (Song et al., 2002; Vicario-Abejo´n et al., 2000;
Wernig et al., 2004). Cells exhibiting only a subset of these prop-
erties should be termed ‘‘partially reprogrammed iN cells.’’ Since
the reprogramming process mimics neuronal maturation, the
term ‘‘immature iN cells’’ could be used alternatively. We would
like to point out, however, that at a practical level it is difficult to
distinguish these two conceptually very different interpretations.
Despite the great diversity of neurons in the nervous system,
there are a number of typical properties shared by the vast
majority of neurons. First, neurons have common morphological
features. They are characterized by cellular polarization and typi-
cally extend multiple arborizing dendrites and one single axon
from the cell body (soma). Because of these unique structural
properties, neurons also express specific cytoskeletal proteins
such as neurofilaments, microtubules, and microtubule-associ-
ated proteins. Second, neurons have unique membrane charac-
teristics, with the presence of numerous constitutively open,
voltage-gated, or transmitter-dependent ion channels and intra-
cellular second messenger-regulated metabotropic receptors.
Together, these proteins confer the passive and active
membrane properties of neurons, such as the ability to generate
action potentials. Finally, neurons are characterized by theirCell Stem Cell 9, December 2, 2011 ª2011 Elsevier Inc. 521
Figure 3. Neuronal Properties in Order of
Stringency (Maturation/Extent of Reprogramming)
Diagrammed here are characteristic properties of neurons
and the specific criteria and assays that can be applied to
evaluate iN cell maturation. The degree of reprogramming
increases from top to bottom as indicated by the shaded
triangle.
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between neurons where neurotransmission takes place. It is
important to note that not all neurons receive synaptic input
from other neurons (e.g., primary sensory neurons), but every
neuron has output function and in most cases forms synapses
with other neurons (one exception are neuromodulatory neurons
such as some dopamine neurons, which are believed to not form
classical synapses).
Building on the generic properties of neurons, we would like to
propose criteria to define a fully reprogrammed iN cell (Figure 3).
Similar to the maturation process of cultured primary neurons,
reprogramming fibroblasts gradually and asynchronously
acquire the full set of neuronal properties over time (Vierbuchen
et al., 2010). Therefore, at any given time there will be a heteroge-
neous population containing iN cells that are reprogrammed to
different degrees and thus display a range of neuronal features.
Figure 3 shows such properties in the order of stringency, which
is also roughly the order of appearance in reprogrammed iN cells
or neurons during development. These properties, therefore, can
serve as criteria to help define the degree of reprogramming or
the maturation stage of iN cells.
The earliest notable changes of converted iN cells aremorpho-
logical, with the generation of a round soma protruding one small
and thin process (Vierbuchen et al., 2010, see also Figure 4B).
Gradually, more processes are generated, which begin to
branch. At first all neurites express both axonal and dendritic
markers, but early during differentiation one process gains the
characteristics of an axon whereas the remaining neurites
become dendrites (e.g., MAP2 versus Tau; see Silverman
et al., 2001). During the early stages of neurogenesis, newly
born neurons become immunoreactive for the nuclear epitope
NeuN (Mullen et al., 1992) and Poly-Sialated Neural Cell Adhe-
sion Molecule (PSA-NCAM) (Bonfanti et al., 1992). Note that
the presence of Tuj1 or MAP2 reactivity in neuritic extensions
of a cell does not necessarily mean that the respective cell is
actually a neuron.
During iN cell reprogramming, both passive and active
membrane properties gradually approach the levels seen in
primary cultured neurons (Vierbuchen et al., 2010). The resting
membrane potential becomes more hyperpolarized and the
capacitance increases as the cell volume increases. The input
resistance also decreases, presumably as a result of the appear-522 Cell Stem Cell 9, December 2, 2011 ª2011 Elsevier Inc.ance of more neuronal membrane channel
proteins. As for passive membrane properties,
under current-clamp recording mode, action-
potential-like responses induced by depolariza-
tion grow to resemble a mature stereotypic
shape with increasing amplitudes and narrow-
ing widths. A mature, all-or-none action poten-
tial is characterized by a constantly high ampli-tude irrespective of the induction and current, with a fast
depolarization and fast repolarization. The rapid repolarization
ensures the regeneration of voltage-gated Na+ channels, which
enables mature cells to fire trains of action potentials in rapid
succession (Koester and Siegelbaum, 2000; Lockery et al.,
2009). Therefore, the presence of repetitive action potentials is
a clear sign that the ion channels responsible for generating
action potentials are properly orchestrated. Repetitive action
potentials occur spontaneously or can be evoked by injecting
currents. However, the presence of spontaneous action
potentials does not necessarily mean that the cells are receiving
excitatory synaptic input, as both spontaneous membrane fluc-
tuations and various pace-making channels (e.g., hyperpolariza-
tion-activated cyclic nucleotide-gated channels) can cause
spontaneous firing. The development of passive and active
membrane properties is facilitated by, but not dependent on,
the presence of glial cells (Wu et al., 2007). By contrast, however,
the formation of functional synapses requires factors secreted
by glial cells (Banker, 1980; Eroglu and Barres, 2010; Wu et al,
2007). Morphological evidence of synapse formation can be ob-
tained by high-resolution fluorescence microscopy showing
a presynaptic vesicle protein such as synapsin, synaptophysin,
or synaptotagmin localized in small puncta in close proximity
to MAP2-positive dendrites. Electron microscopic analysis and
demonstration of a postsynaptic density as well as synaptic vesi-
cles in the presynaptic axonal compartment can provide even
stronger evidence. Morphology alone does not prove the exis-
tence of functional synapses, but unambiguous evidence of
synaptic transmission can be obtained using electrophysiolog-
ical tools (Regehr and Stevens, 2001). A prerequisite for synaptic
transmission is the expression of certain ionotropic neurotrans-
mitter receptors, which can be tested by exposing the cells to
specific receptor agonists such as glutamate or GABA and
determining the current responses in the presence and absence
of channel blockers to show specificity. The expression of neuro-
transmitter receptors is still not proof of function. The presence
of functional synapses can be unambiguously demonstrated
by the recording of typical spontaneous postsynaptic currents
(PSCs) with sharp rise and slow decay phases caused by both
the dynamics of presynaptic vesicle exocytosis and the biophys-
ical properties of postsynaptic receptors (Figures 4D and 4E).
PSCs can be recorded spontaneously or evoked by stimulation
Figure 4. Examples of Morphological and Electrophysiological Criteria of iN Cells
(A) Tuj1-positive fibroblasts extending one or more thin cellular process.
(B) Immature iN cells extending one or two long branching neurites from their soma.
(C) More mature iN cell morphologies characterized by multiple, long, branching processes extending from the cell body. Often iN cells sit on top of a dense
network of neurites derived from surrounding cells.
(D) A voltage-clamp recording of spontaneous PSCs. The baseline is fairly tight and there is only little noise detectable. Both clusters of spikes (region 1, black)
and separated spikes (region 2, red) representmost likely postsynaptic events as seen by higher time resolution (lower black and red traces). PSCs are typically of
asymmetric shape with a fast deviation from the baseline followed by a slow rectification.
(E) A trace in the same recording mode with a much noisier baseline. Region 1 shows a group of spikes with amplitude deviation similar to that in (D). Higher
resolution (lower black trace) reveals high levels of baseline fluctuation precluding the identification of PSCs. Other areas in the same trace (e.g., region 2, red
trace) contain spikes that most likely represent synaptic currents.
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from the differences in kinetics between excitatory and inhibitory
PSCs, application of specific neurotransmitter receptor blockers
can demonstrate specificity of the responses and distinguish
inhibitory (IPSC) from excitatory (EPSC) postsynaptic activity.
Sometimes, noise caused by fluctuation of membrane channels
during the recording can cause membrane potential deflections
that appear to be synaptic currents (Figure 4D1). Therefore, not
every deviation from the baseline is mediated by synaptic trans-
mission, and cautious interpretation of the recorded traces is
essential. The evaluation of presynaptic competence is in our
view not only the most rigorous criterium of neuronal function,
but is also the most difficult test, as it requires either the culture
of pure iN cells in a sufficient density or paired recordings.
Finally, mature synapses also often show simple short-term
plasticity such as depression or facilitation.
In summary, we propose distinguishing fully and partially re-
programmed iN cells based on a specific combination of molec-
ular and functional characteristics. We suggest that the critical
feature of fully reprogrammed iN cells should be the demonstra-
tion of synaptic competence as determined by the presence
of spontaneous and evoked presynaptic and postsynaptic
responses in mixed or pure neuronal cultures. iN cells can also
be assessed either in vitro or after transplantation into rodent
brains, which may provide a better environment for maturation.
Outlook and Concluding Remarks
Although still in a nascent stage, the field of direct somatic
lineage reprogramming has already attracted a lot of attention.
From a biological standpoint, it may become a newmethodologyin the developmental and molecular biology toolbox. It offers
a new way to interrogate transcription factor function indepen-
dent of the physiological environment, and to study the complex
interplay between sequence-specific transcriptional regulators
and various repressive and active chromatin states, as well
as the recruitment of their underlying chromatin-modifying
enzymes. Moreover, the generation of iN cells represents a novel
way to study the mechanisms of cell fate decisions of neural
development and postmitotic neuronal maturation. In addition,
the use of human iN cells provides an avenue for studying human
developmental processes in live cultures, which may enable the
discovery of species-specific differences relative to the much-
better-studied model organisms.
From a medical point of view, direct lineage reprogramming
provides an alternative, potentially complementary tool to
many of the proposed applications of iPSC technology for both
disease modeling and development of cell-based therapies.
Recently, several elegant reports of assessing disease-related
phenotypes in iPSC-derived neurons have provided an impor-
tant proof-of-principle that at least some cellular aspects of
complex brain diseases can be recapitulated with patient-
derived cells in vitro (Marchetto et al., 2010; Brennand et al.,
2011; Nguyen et al., 2011). Both iPSC and iN cell approaches
are complicated by heterogeneity with respect to maturation
and presumably subtype specification. Especially iPSCs have
shown a substantial line-to-line variability with regards to differ-
entiation potential (Hu et al., 2010). Future studies will show
whether directly generated iN cells can provide a better repre-
sentation of the cellular variability, which might in turn simplify
the discovery and analysis of disease-associated phenotypes.Cell Stem Cell 9, December 2, 2011 ª2011 Elsevier Inc. 523
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ReviewMoreover, the generation of iN cells from a large cohort of
patients appears quite feasible, whereas the generation and
neuronal differentiation of iPSCs would be a very cumbersome
and slow process.
For potential use in regenerativemedicine, both iPS and iN cell
approaches could provide autologous neuronal donor cells for
transplantation. Expandability is obviously a major advantage
of iPSCs over postmitotic iN cells and may very well be a limiting
factor. However, the postmitotic state of iN cells would have the
advantage of a much lower risk of cancer and teratoma forma-
tion. Integration-free iN cells would be preferable for clinical
use. Along those lines, it will be exciting to see whether small
molecules can be found to replace some or all transcription
factors, similar to the recent successes in iPSCs. Finally, future
studies will need to improve iN cell generation from adult human
fibroblasts since the current low efficiencies represent another
hurdle for any of these translational applications.
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